Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2012
11/01/2012WO2012146763A1 Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat
11/01/2012WO2012146642A1 Administration of iloprost as aerosol bolus
11/01/2012WO2012146592A1 Controlled release tablet of ginkgo biloba extract and procedure for obtaining it
11/01/2012WO2012146314A1 Thin gelatin capsules for rapid drug release in the mouth
11/01/2012WO2012146218A1 Amphoteric materials based on crosslinked hyaluronic acid, method of preparation thereof, materials containing entrapped active agents, method of preparation thereof, and use of said materials
11/01/2012WO2012146110A1 Insulin-delivering transdermal formulation and preparation method therefor
11/01/2012WO2012146057A1 Curcuminoid injection solution and intravenous injection
11/01/2012WO2012146052A1 Risperidone sustained release microsphere composition
11/01/2012WO2012146049A1 Traditional chinese medicine composition for treating oral cavity disease and the preparation technology and the quality testing method thereof
11/01/2012WO2012145801A1 Nanoparticle
11/01/2012WO2012122535A3 Stable formulations for parenteral injection of peptide drugs
11/01/2012WO2012122295A3 Treatment for pancreatic adenocarcinoma and other cancers of epithelial origin
11/01/2012WO2012121528A3 Magnetic nanocomposite specific for thyroid cancer and use thereof
11/01/2012WO2012121523A3 Process for preparing pharmaceutical formulation in form of antioxidant-free solution for injection containing pemetrexed or its salt
11/01/2012WO2012111965A3 Orally administered sustained-release triple-layer pill containing tamsulosin or pharmaceutically acceptable salt thereof
11/01/2012WO2012110971A3 Method and composition to retard sorption of preservatives to plastics
11/01/2012WO2012110886A4 Controlled-release formulation comprising hcg
11/01/2012WO2012108648A3 Method of preparing iron oxide nanoparticles coated with hydrophilic material, and magnetic resonance imaging contrast agent using the same
11/01/2012WO2012104275A3 Nanoparticles delivery systems, preparation and uses thereof
11/01/2012WO2012103544A3 Detachable drug delivery device
11/01/2012WO2012094574A3 Stabilized polyribonucleotide nanoparticles
11/01/2012WO2012092510A3 Ocular drug delivery system
11/01/2012WO2012092486A3 Modified release benzimidazole formulations
11/01/2012WO2012092305A3 Nanonized iron compositions and methods of use thereof
11/01/2012WO2012090070A3 Biodegradable drug delivery compositions
11/01/2012WO2012085847A3 Triggered polymer viscous pill and methods of using the same
11/01/2012WO2012083138A3 Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
11/01/2012WO2012058668A3 Ternary mixture formulations
11/01/2012US20120277772 Hppe yarns
11/01/2012US20120277573 Ultrasound-activated nanoparticles as imaging agents and drug delivery vehicles
11/01/2012US20120277517 Formulation and Methods for Enhanced Interventional Image-Guided Therapy of Cancer
11/01/2012US20120277315 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
11/01/2012US20120277267 Method of managing or treating pain
11/01/2012US20120277261 Pharmaceutical formulations useful in the treatment of insomnia
11/01/2012US20120277235 Compositions For Topical Application Having Androgenic Actions
11/01/2012US20120276211 Polymerizable lactamic copolymers suitable for the formation of coatings on microencapsulated particles
11/01/2012US20120276210 Shampoo Compositions with Increased Deposition of Polyacrylate Microcapsules
11/01/2012US20120276209 Nucleic acid-containing lipid particles and related methods
11/01/2012US20120276208 Acute cognitive and mood effects of plant polysaccharides in adult human subjects
11/01/2012US20120276207 Methods for preparation of lipid-encapsulated therapeutic agents
11/01/2012US20120276206 Method for manufacturing acid pellets
11/01/2012US20120276205 Silver oxide formulations
11/01/2012US20120276204 Bone Growth Compositions and Methods
11/01/2012US20120276203 Collagen matrix for cell therapy
11/01/2012US20120276202 Collagen matrix for tissue engineering
11/01/2012US20120276201 Compositions and method for treatment and prophylaxis of inflammatory bowel disease
11/01/2012US20120276200 Formulations of quinolinones
11/01/2012US20120276199 Taste masked pharmaceutical formulations
11/01/2012US20120276198 Pharmaceutical composition for treating parkinson's disease and preparation method thereof
11/01/2012US20120276197 Dosage Form to Increase Prasterone Bioavailability
11/01/2012US20120276196 Pharmaceutical Compositions of a Neuroactive Steroid and Methods of Use Thereof
11/01/2012US20120276195 Indole Alkaloid Derivatives Having Opioid Receptor Agonistic Effect, And Therapeutic Compositions And Methods Relating To Same
11/01/2012US20120276194 Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof
11/01/2012US20120276193 Agents, Uses and Methods
11/01/2012US20120276192 Compositions and methods for sirna inhibition of icam-1
11/01/2012US20120276191 Treatment and Diagnosis of Macrophage Mediated Disease
11/01/2012US20120276190 Therapy with a chimeric molecule and a pro-apoptotic agent
11/01/2012US20120276189 Therapeutic Treatment of Dermatologic Skin Disorders
11/01/2012US20120276188 Biomaterials made from human hair
11/01/2012US20120276187 Tabletted chewing gum sweet
11/01/2012US20120276185 Soluble coating comprising polyelectrolyte with hydrophobic counterions
11/01/2012US20120276184 Solvent cast film sustained release latanoprost implant
11/01/2012US20120276182 Methods of treating fungal, yeast and mold infections
11/01/2012US20120276180 Active Agent Delivery and/or Odor Retentive Composition and Methods of Use Thereof
11/01/2012US20120276177 Visually patterned and oriented compositions
11/01/2012US20120276175 Personal Cleansing Compositions with Increased Deposition of Polyacrylate Microcapsules
11/01/2012US20120276173 Glycosaminoglycan Compositions in Combination with Stem Cells
11/01/2012US20120276172 Polymeric materials for medical devices
11/01/2012US20120276171 Micelle encapsulation of therapeutic agents
11/01/2012US20120276170 Injectable drug carrier comprising layered double hydroxide
11/01/2012US20120276169 Polymer nanoparticle injection formulation composition containing rapamycin with improved water solubility, preparation method thereof, and anticancer composition for combined use with radiotherapy
11/01/2012US20120276168 Amino acid conjugates of quetiapine, process for making and using the same
11/01/2012US20120276167 Immunoprotection by oral administration of recombinant lactococcus lactis mini-capsules
11/01/2012US20120276166 Elution-stabilized preparation
11/01/2012US20120276165 Micro-colloidal silicic acid/boric acid composition and a method of preparing a bioenhancing solution and powder
11/01/2012US20120276164 Implantable paste and its use
11/01/2012US20120276163 Anti-cancer composition comprising alginate
11/01/2012US20120276162 Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same
11/01/2012US20120276161 Bioresorbable and biocompatible compounds for surgical use
11/01/2012US20120276160 Tolerogenic synthetic nanocarriers for regulating innate immune responses
11/01/2012US20120276159 Tolerogenic synthetic nanocarriers
11/01/2012US20120276158 Tolerogenic synthetic nanocarriers to reduce cytotoxic t lymphocyte responses
11/01/2012US20120276157 Tolerogenic synthetic nanocarriers to reduce antibody responses
11/01/2012US20120276156 Tolerogenic synthetic nanocarrier compositions with transplantable graft antigens and methods of use
11/01/2012US20120276155 Tolerogenic synthetic nanocarriers for generating cd8+ regulatory t cells
11/01/2012US20120276153 Use of aerosolized levofloxacin for treating cystic fibrosis
11/01/2012US20120276152 Systems and methods of using zinc-chelator to treat myocardial infarction
11/01/2012US20120276151 Drug delivery from embolic agents
11/01/2012US20120276150 Soft tissue wrap
11/01/2012US20120276116 Prevention and Treatment of Amyloidogenic Disease
11/01/2012US20120276019 Tissue kallikrein for the treatment of parkinson's disease
11/01/2012US20120276018 Alkaloid ester and carbamate derivatives and medicinal compositions thereof
11/01/2012US20120276017 Methods and Compositions for Treatment of Attention Deficit Disorder
11/01/2012US20120273589 Electronic cigarette
11/01/2012CA2834619A1 Controlled release of immunosuppressants from synthetic nanocarriers
11/01/2012CA2834599A1 Tolerogenic synthetic nanocarriers for antigen-specific deletion of t effector cells
11/01/2012CA2834571A1 Tolerogenic synthetic nanocarriers for inducing regulatory b cells
11/01/2012CA2834534A1 Tolerogenic synthetic nanocarriers for generating cd8+ regulatory t cells
11/01/2012CA2834533A1 Tolerogenic synthetic nanocarriers for allergy therapy
11/01/2012CA2834532A1 Tolerogenic synthetic nanocarriers to reduce cytotoxic t lymphocyte responses
1 ... 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 ... 2991